Community Support and Mobile Apps to Help Black Women Control High Blood Pressure After Pregnancy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age19-50
SponsorUniversity of Nebraska

About this trial

The goal of this randomized clinical trial is to evaluate the effectiveness of a collaborative care intervention, consisting of remote blood pressure monitoring and support from community health workers, in improving blood pressure control and reducing postpartum complications among Black women with hypertensive disorders of pregnancy (HDP). The primary objectives are to determine whether the intervention leads to improved blood pressure control at 12 months postpartum compared to standard care, and whether it reduces the incidence of serious maternal morbidity, including hospitalizations and cardiovascular events. Secondary objectives include examining whether patient activation and trust in the healthcare system mediate the relationship between the intervention and clinical outcomes. Participants will be enrolled at approximately 6 weeks postpartum and randomized to either the collaborative care intervention or standard postpartum care. All participants will self-monitor blood pressure using a provided device, receive guidance on hypertension management, and complete study assessments at multiple time points. Participants assigned to the intervention arm will additionally receive ongoing support from community health workers, including health education, care coordination, and assistance with healthcare navigation. Clinical outcomes and patient-reported measures will be assessed over a 12-month follow-up period.

Eligibility criteria

Qualifiers

Black/ African American patients

Age: 19 and 50 years of age

Diagnosis: Hypertension Disorders of Pregnancy

Enrolled in STAMPP-HTN for first 6 weeks postpartum

Disqualifiers

Age: <19 years

Significant Kidney or Liver disease that may limit antihypertensive medication adjustment

Trial design

Treatments tested in this trial

  • Collaborative care
  • Standard of Care (SOC)

Treatment groups

404 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators